(NASDAQ: SCLX) Scilex Holding Co's forecast annual revenue growth rate of 162.27% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.93%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.47%.
Scilex Holding Co's revenue in 2026 is $31,608,000.On average, 3 Wall Street analysts forecast SCLX's revenue for 2026 to be $571,748,760, with the lowest SCLX revenue forecast at $549,327,240, and the highest SCLX revenue forecast at $588,564,900. On average, 3 Wall Street analysts forecast SCLX's revenue for 2027 to be $1,636,940,820, with the lowest SCLX revenue forecast at $1,572,818,670, and the highest SCLX revenue forecast at $1,685,096,130.
In 2028, SCLX is forecast to generate $5,271,095,520 in revenue, with the lowest revenue forecast at $5,064,460,830 and the highest revenue forecast at $5,426,177,700.